Award recordCONTRACT

ASTELLAS PHARMA US, INC.

PIID 36E79719A0025· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $0 net obligations· UEI NKGHPQKJQWC1· IL

Description

BPA CANCELLATION.

Base award description: BPA FOR XTANDI

First action · last action
2019-07-19 · 2021-09-27
Transactions
12
First transaction's obligation
$0
Base + all options value (sum of deltas)
$1,094,225
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D30296
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 12 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2019-07-19 · this action $0 · running total $0Modification P00001 · 2019-10-11 · this action $0 · running total $0Modification P00002 · 2019-10-11 · this action $0 · running total $0Modification P00003 · 2019-12-27 · this action $0 · running total $0Modification P00004 · 2020-05-28 · this action $0 · running total $0Modification P00005 · 2020-12-23 · this action $0 · running total $0Modification P00007 · 2021-03-22 · this action $0 · running total $0Modification P00008 · 2021-05-19 · this action $0 · running total $0Modification P00009 · 2021-05-21 · this action $0 · running total $0Modification P00010 · 2021-06-08 · this action $0 · running total $0Modification P00011 · 2021-09-27 · this action $0 · running total $0Modification P00012 · 2021-09-27 · this action $0 · running total $0
  • Base2019-07-19+$0= $0
  • Mod P000012019-10-11+$0= $0
  • Mod P000022019-10-11+$0= $0
  • Mod P000032019-12-27+$0= $0
  • Mod P000042020-05-28+$0= $0
  • Mod P000052020-12-23+$0= $0
  • Mod P000072021-03-22+$0= $0
  • Mod P000082021-05-19+$0= $0
  • Mod P000092021-05-21+$0= $0
  • Mod P000102021-06-08+$0= $0
  • Mod P000112021-09-27+$0= $0
  • Mod P000122021-09-27+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-07-19+$0$0BPA FOR XTANDI
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2019-10-11+$0$0PRICE REDUCTION EFFECTIVE 10/15/19 - 12/31/19
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2019-10-11+$0$0PRODUCT ADDITION XOSPATA
Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2019-12-27+$0$02020 PUBLIC LAW UPDATES AND TEMPORARY PRICE REDUCTION
Mod P00004· EXERCISE AN OPTION2020-05-28+$0$0EXERCISE OPTION YEAR 1
Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2020-12-23+$0$02021 PUBLIC LAW PRICING UPDATES
Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-03-22+$0$0PRODUCT ADDITION OF TWO XTANDI NDCS
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-05-19+$0$0TEMPORARY PRICE REDUCTION ON ONE XTANDI NDC.
Mod P00009· EXERCISE AN OPTION2021-05-21+$0$0EXERCISE THE 2ND OPTION YEAR ON BPA 36E79719A0025.
Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-06-08+$0$0PRICE CHANGE FOR TWO XTANDI NDCS.
Mod P00011· OTHER ADMINISTRATIVE ACTION2021-09-27+$0$0PRICE CHANGE FOR THREE XTANDI NDCS.
Mod P00012· LEGAL CONTRACT CANCELLATION2021-09-27+$0$0BPA CANCELLATION.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NKGHPQKJQWC1)

AwardOffice · PSC / listingNet obligationsFY
36E79722A0001NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
36F79721D0260NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2021
VA24817F2692248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$145,897FY2017
VA24817F2026248-NETWORK CONTRACT OFFICE 8 (36C248) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY$243,162FY2017
VA24817F0523248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$243,162FY2017
VA24117J0582241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$108,180FY2017

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79719A0025_3600 · retrieved 2026-09-26.